{"count":25,"summary":"Found 25 ATM offerings in the past 72 hours. Top filers: Ultra Clean Holdings, Inc., Outlook Therapeutics, Inc., CURIS INC.","filings":[{"accession_number":"0000950103-26-012378","company_name":"Ultra Clean Holdings, Inc.","filed_at":"2026-08-14T08:45:49-04:00","cik":"1275014","form_type":"424B5","shelf_size_usd":400000000,"shelf_size_million_usd":400.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-9 MATERIAL UNITED STATES FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF COMMON STOCK S-10 PLAN OF DISTRIBUTION S-13 LEGAL MATTERS S-15 EXPERTS S-15 Prospectus Page Ultra Clean Holdings, Inc. 1 About This Prospectus 1 Forward-L"},{"accession_number":"0001104659-26-096504","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-08-14T08:30:37-04:00","cik":"1649989","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["H.C. Wainwright","BTIG","Piper Sandler"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-12 ​ ​ DILUTION ​ ​ ​ ​ S-13 ​ ​ Description of Securities We Are Offering ​ ​ ​ ​ S-15 ​ ​ UNDERWRITING ​ ​ ​ ​ S-24 ​ ​ LEGAL MATTERS ​ ​ ​ ​ S-33 ​ ​ EXPERTS ​ ​ ​ ​ S-33 ​ ​ WHERE YOU CAN FIND MORE INFORMATION ​ ​ ​ ​ S-33 ​ ​ INCORPORA"},{"accession_number":"0001108205-26-000116","company_name":"CURIS INC","filed_at":"2026-08-13T17:27:13-04:00","cik":"1108205","form_type":"424B4","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["A.G.P./Alliance Global Partners"],"use_of_proceeds_excerpt":"13 Selected Financial Data 14 Capitalization 15 Dilution 16 Dividend Policy 18 Description of Securities We are Offering 19 Plan of Distribution 25 Material U.S. Federal Income Tax Consequences 28 Legal Matters 35 Experts 36 Where You Can Find More I"},{"accession_number":"0001628280-26-056802","company_name":"CapsoVision, Inc","filed_at":"2026-08-13T16:46:45-04:00","cik":"1378325","form_type":"S-3","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald"],"use_of_proceeds_excerpt":"8 DESCRIPTION OF CAPITAL STOCK 9 DESCRIPTION OF WARRANTS 14 DESCRIPTION OF RIGHTS 16 DESCRIPTION OF UNITS 17 PLAN OF DISTRIBUTION 18 LEGAL MATTERS 20 EXPERTS 20 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-3 t"},{"accession_number":"0001140361-26-032832","company_name":"ONE LIBERTY PROPERTIES INC","filed_at":"2026-08-13T16:31:41-04:00","cik":"712770","form_type":"S-3","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"7 DESCRIPTION OF CAPITAL STOCK 8 DESCRIPTION OF WARRANTS 10 DESCRIPTION OF SUBSCRIPTION RIGHTS 11 PROVISIONS OF MARYLAND LAW AND OF OUR CHARTER AND BYLAWS 12 FEDERAL INCOME TAX CONSIDERATIONS 16 STATE AND LOCAL TAXES 35 IMPORTANCE OF OBTAINING PROFES"},{"accession_number":"0001193125-26-349330","company_name":"Seres Therapeutics, Inc.","filed_at":"2026-08-13T16:31:15-04:00","cik":"1609809","form_type":"S-3","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Cowen"],"use_of_proceeds_excerpt":"6 DESCRIPTION OF CAPITAL STOCK 7 DESCRIPTION OF DEBT SECURITIES 10 DESCRIPTION OF WARRANTS 18 DESCRIPTION OF UNITS 20 GLOBAL SECURITIES 21 PLAN OF DISTRIBUTION 25 LEGAL MATTERS 27 EXPERTS 27 ABOUT THIS PROSPECTUS This prospectus is part of a registra"},{"accession_number":"0001193125-26-349250","company_name":"CAMPBELL'S Co","filed_at":"2026-08-13T16:16:51-04:00","cik":"16732","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"5 Description of Debt Securities 5 Description of Capital Stock 16 Description of Preferred Stock 19 Description of Other Securities 19 Plan of Distribution 19 Legal Opinions 20 Experts 21 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is "},{"accession_number":"0001628280-26-056729","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2026-08-13T16:14:20-04:00","cik":"1725160","form_type":"424B5","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":["Cowen","Guggenheim"],"use_of_proceeds_excerpt":"S-12 DIVIDEND POLICY S-13 DILUTION S-14 DESCRIPTION OF PRE-FUNDED WARRANTS S-16 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES S-17 UNDERWRITING S-23 LEGAL MATTERS S-31 EXPERTS S-31 WHERE YOU CAN FIND MORE INFORMATION S-31 INCORPORATION BY REFERENCE S"},{"accession_number":"0001104659-26-095880","company_name":"Haleon US Capital LLC","filed_at":"2026-08-13T16:01:44-04:00","cik":"2149389","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["Citigroup Global Markets","Goldman Sachs"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-10 ​ ​ Capitalization and Indebtedness ​ ​ ​ ​ S-11 ​ ​ United States Taxation ​ ​ ​ ​ S-13 ​ ​ United Kingdom Taxation ​ ​ ​ ​ S-14 ​ ​ Underwriting (Conflicts of interest) ​ ​ ​ ​ S-15 ​ ​ Where You Can Find More Information About Us ​ ​ "},{"accession_number":"0001178913-26-004116","company_name":"Silexion Therapeutics Corp","filed_at":"2026-08-13T11:01:15-04:00","cik":"2022416","form_type":"424B4","shelf_size_usd":15000000,"shelf_size_million_usd":15.0,"is_atm":true,"sales_agents":["H.C. Wainwright"],"use_of_proceeds_excerpt":"40 Capitalization 41 Market Information for Securities and Dividend Policy 42 Management’s Discussion and Analysis of Financial Condition and Results of Operations 43 Business 60 Management 86 Executive Compensation 92 Certain Relationships and Relat"},{"accession_number":"0001193125-26-348013","company_name":"ADVANCED MICRO DEVICES INC","filed_at":"2026-08-13T08:48:12-04:00","cik":"2488","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"6 Description of Debt Securities 7 Global Securities 15 Plan of Distribution 19 Legal Matters 20 Experts 20 Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchang"},{"accession_number":"0001193125-26-347943","company_name":"Savers Value Village, Inc.","filed_at":"2026-08-13T08:09:52-04:00","cik":"1883313","form_type":"424B5","shelf_size_usd":50000000,"shelf_size_million_usd":50.0,"is_atm":true,"sales_agents":["Jefferies","BTIG","Piper Sandler","Goldman Sachs"],"use_of_proceeds_excerpt":"S-14 DIVIDEND POLICY S-15 SELLING STOCKHOLDERS S-16 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS S-18 UNDERWRITING S-22 LEGAL MATTERS S-32 EXPERTS S-32 ABOUT THIS PROSPECTUS 1 INCORPORATION BY REFERENCE 3 SPECIAL NOTE REGARDING FORWARD-LOOKING STA"},{"accession_number":"0001213900-26-088706","company_name":"VEEA INC.","filed_at":"2026-08-13T08:00:19-04:00","cik":"1840317","form_type":"424B5","shelf_size_usd":75000000,"shelf_size_million_usd":75.0,"is_atm":true,"sales_agents":["Roth Capital"],"use_of_proceeds_excerpt":"S-9 DIVIDEND POLICY S-10 DILUTION S-11 PLAN OF DISTRIBUTION S-12 LEGAL MATTERS S-14 EXPERTS S-14 WHERE YOU CAN FIND MORE INFORMATION S-14 INCORPORATION BY REFERENCE S-15 Prospectus Page ABOUT THIS PROSPECTUS ii RISK FACTORS 1 CAUTIONARY NOTE REGARDIN"},{"accession_number":"0001193125-26-347828","company_name":"enCore Energy Corp.","filed_at":"2026-08-13T06:51:30-04:00","cik":"1500881","form_type":"424B5","shelf_size_usd":700000000,"shelf_size_million_usd":700.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald","B. Riley Securities"],"use_of_proceeds_excerpt":"S-6 DILUTION S-7 PLAN OF DISTRIBUTION S-8 CANADIAN TAX PROPOSAL S-10 WHERE YOU CAN FIND MORE INFORMATION S-11 DOCUMENTS INCORPORATED BY REFERENCE S-11 LEGAL MATTERS S-13 EXPERTS S-13 Prospectus ABOUT THIS PROSPECTUS 1 CAUTIONARY NOTE REGARDING FORWAR"},{"accession_number":"0001753926-26-001459","company_name":"Rocket Lab Corp","filed_at":"2026-08-13T06:24:14-04:00","cik":"1819994","form_type":"424B5","shelf_size_usd":3000000000,"shelf_size_million_usd":3000.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-20 DIVIDEND POLICY S-21 DILUTION S-22 PLAN OF DISTRIBUTION (CONFLICTS OF INTEREST) S-30 LEGAL MATTERS S-37 EXPERTS S-37 WHERE YOU CAN FIND MORE INFORMATION S-37 INCORPORATION BY REFERENCE S-38 Prospectus Page ABOUT THIS PROSPECTUS 1 RISK FACTORS 2 "},{"accession_number":"0001213900-26-088617","company_name":"SunScout Holding Ltd","filed_at":"2026-08-12T21:32:28-04:00","cik":"2101240","form_type":"424B4","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"41 CAPITALIZATION 43 DILUTION 45 DIVIDENDS AND DIVIDEND POLICY 46 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 47 HISTORY AND CORPORATE STRUCTURE 67 INDUSTRY OVERVIEW 70 BUSINESS 80 REGULATIONS 109 MANAGEMENT "},{"accession_number":"0001193125-26-347191","company_name":"Silence Therapeutics plc","filed_at":"2026-08-12T17:21:05-04:00","cik":"1479615","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald","Jefferies","Morgan Stanley"],"use_of_proceeds_excerpt":"S-9 DIVIDEND POLICY S-10 DILUTION S-11 UNDERWRITING S-13 MATERIAL TAX CONSIDERATIONS S-22 LEGAL MATTERS S-30 EXPERTS S-30 SERVICE OF PROCESS AND ENFORCEMENT OF LIABILITIES S-31 WHERE YOU CAN FIND ADDITIONAL INFORMATION S-33 INCORPORATION BY REFERENCE"},{"accession_number":"0001104659-26-094970","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-08-12T16:49:41-04:00","cik":"1649989","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["H.C. Wainwright","BTIG","Piper Sandler"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-12 ​ ​ DILUTION ​ ​ ​ ​ S-13 ​ ​ Description of Securities We Are Offering ​ ​ ​ ​ S-15 ​ ​ UNDERWRITING ​ ​ ​ ​ S-24 ​ ​ LEGAL MATTERS ​ ​ ​ ​ S-33 ​ ​ EXPERTS ​ ​ ​ ​ S-33 ​ ​ WHERE YOU CAN FIND MORE INFORMATION ​ ​ ​ ​ S-33 ​ ​ INCORPORA"},{"accession_number":"0001628280-26-056232","company_name":"Allogene Therapeutics, Inc.","filed_at":"2026-08-12T16:22:44-04:00","cik":"1737287","form_type":"S-3","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"7 DESCRIPTION OF CAPITAL STOCK 8 DESCRIPTION OF DEBT SECURITIES 12 DESCRIPTION OF WARRANTS 19 LEGAL OWNERSHIP OF SECURITIES 22 PLAN OF DISTRIBUTION 25 LEGAL MATTERS 27 EXPERTS 27 WHERE YOU CAN FIND MORE INFORMATION 27 INCORPORATION OF CERTAIN INFORMA"},{"accession_number":"0001104659-26-094850","company_name":"Datavault AI Inc.","filed_at":"2026-08-12T16:02:09-04:00","cik":"1682149","form_type":"S-3","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["Maxim Group"],"use_of_proceeds_excerpt":"​ ​ ​ ​ 11 ​ ​ SELLING STOCKHOLDER TRANSACTIONS ​ ​ ​ ​ 12 ​ ​ SELLING STOCKHOLDER ​ ​ ​ ​ 14 ​ ​ DESCRIPTION OF CAPITAL STOCK ​ ​ ​ ​ 15 ​ ​ PLAN OF DISTRIBUTION ​ ​ ​ ​ 16 ​ ​ DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES ACT "},{"accession_number":"0001213900-26-088085","company_name":"CleanCore Solutions, Inc.","filed_at":"2026-08-12T09:12:29-04:00","cik":"1956741","form_type":"424B5","shelf_size_usd":1000000000,"shelf_size_million_usd":1000.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald","Maxim Group"],"use_of_proceeds_excerpt":"S-9 Dividend Policy S-9 Dilution S-10 Description of Securities We Are Offering S-11 Plan of Distribution S-14 Legal Matters S-16 Experts S-16 Where You Can Find More Information S-16 Documents Incorporated By Reference S-17 PROSPECTUS Page Prospectu"},{"accession_number":"0001213900-26-087891","company_name":"Tenon Medical, Inc.","filed_at":"2026-08-11T17:30:23-04:00","cik":"1560293","form_type":"S-3","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":["A.G.P./Alliance Global Partners"],"use_of_proceeds_excerpt":"7 SELLING SECURITY HOLDERS 8 DESCRIPTION OF SECURITIES 9 DESCRIPTION OF COMMON STOCK 10 DESCRIPTION OF PREFERRED STOCK 12 DESCRIPTION OF WARRANTS 13 DESCRIPTION OF DEBT SECURITIES 16 DESCRIPTION OF RIGHTS 23 DESCRIPTION OF UNITS 24 PLAN OF DISTRIBUTI"},{"accession_number":"0001493152-26-037195","company_name":"Core AI Holdings, Inc.","filed_at":"2026-08-11T17:23:16-04:00","cik":"1649009","form_type":"424B5","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-10 DIVIDEND POLICY S-10 PLAN OF DISTRIBUTION S-11 LEGAL MATTERS S-13 EXPERTS S-13 WHERE YOU CAN FIND MORE INFORMATION S-13 INFORMATION INCORPORATED BY REFERENCE S-14 PROSPECTUS Page ABOUT THIS PROSPECTUS ii CAUTIONARY STATEMENT REGARDING FORWARD-LO"},{"accession_number":"0001193125-26-344989","company_name":"Tango Therapeutics, Inc.","filed_at":"2026-08-11T17:10:45-04:00","cik":"1819133","form_type":"424B5","shelf_size_usd":400000000,"shelf_size_million_usd":400.0,"is_atm":true,"sales_agents":["Leerink"],"use_of_proceeds_excerpt":"S-12 DILUTION S-13 DIVIDEND POLICY S-15 PLAN OF DISTRIBUTION S-16 LEGAL MATTERS S-18 EXPERTS S-18 WHERE YOU CAN FIND MORE INFORMATION S-18 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE S-19 PROSPECTUS ABOUT THIS PROSPECTUS 1 RISK FACTORS 3 SPECIA"},{"accession_number":"0001213900-26-087832","company_name":"Hyliion Holdings Corp.","filed_at":"2026-08-11T16:45:13-04:00","cik":"1759631","form_type":"424B5","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-4 DILUTION S-5 PLAN OF DISTRIBUTION S-6 LEGAL MATTERS S-7 EXPERTS S-7 WHERE YOU CAN FIND MORE INFORMATION S-7 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE S-7 Prospectus Page ABOUT THIS PROSPECTUS ii CAUTIONARY NOTE REGARDING FORWARD-LOOKING S"}],"note":"Showing past 72h. Free 3-day Pro trial (no card): https://filingfirehose.com/trial"}